Caseware UK (AP4) 2022.0.179 2022.0.179 2023-06-302023-06-30true2022-07-01falseNo description of principal activity22trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 10833645 2022-07-01 2023-06-30 10833645 2021-07-01 2022-06-30 10833645 2023-06-30 10833645 2022-06-30 10833645 c:Director1 2022-07-01 2023-06-30 10833645 d:PlantMachinery 2022-07-01 2023-06-30 10833645 d:PlantMachinery 2023-06-30 10833645 d:PlantMachinery 2022-06-30 10833645 d:PlantMachinery d:OwnedOrFreeholdAssets 2022-07-01 2023-06-30 10833645 d:OfficeEquipment 2022-07-01 2023-06-30 10833645 d:CurrentFinancialInstruments 2023-06-30 10833645 d:CurrentFinancialInstruments 2022-06-30 10833645 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 10833645 d:CurrentFinancialInstruments d:WithinOneYear 2022-06-30 10833645 d:ShareCapital 2023-06-30 10833645 d:ShareCapital 2022-06-30 10833645 d:RetainedEarningsAccumulatedLosses 2023-06-30 10833645 d:RetainedEarningsAccumulatedLosses 2022-06-30 10833645 d:AcceleratedTaxDepreciationDeferredTax 2023-06-30 10833645 d:AcceleratedTaxDepreciationDeferredTax 2022-06-30 10833645 c:OrdinaryShareClass1 2022-07-01 2023-06-30 10833645 c:OrdinaryShareClass1 2023-06-30 10833645 c:OrdinaryShareClass1 2022-06-30 10833645 c:OrdinaryShareClass2 2022-07-01 2023-06-30 10833645 c:OrdinaryShareClass2 2023-06-30 10833645 c:OrdinaryShareClass2 2022-06-30 10833645 c:FRS102 2022-07-01 2023-06-30 10833645 c:AuditExempt-NoAccountantsReport 2022-07-01 2023-06-30 10833645 c:FullAccounts 2022-07-01 2023-06-30 10833645 c:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 10833645 d:WithinOneYear 2023-06-30 10833645 d:WithinOneYear 2022-06-30 10833645 d:BetweenOneFiveYears 2023-06-30 10833645 d:BetweenOneFiveYears 2022-06-30 10833645 2 2022-07-01 2023-06-30 10833645 4 2022-07-01 2023-06-30 10833645 e:PoundSterling 2022-07-01 2023-06-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 10833645









J P R MEDICAL LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2023

 
J P R MEDICAL LIMITED
REGISTERED NUMBER: 10833645

BALANCE SHEET
AS AT 30 JUNE 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 3 
16,927
16,664

  
16,927
16,664

Current assets
  

Debtors: amounts falling due within one year
 4 
67,672
57,083

Bank and cash balances
  
266,669
221,774

  
334,341
278,857

Creditors: amounts falling due within one year
 5 
(29,296)
(28,075)

Net current assets
  
 
 
305,045
 
 
250,782

Total assets less current liabilities
  
321,972
267,446

Provisions for liabilities
  

Deferred tax
 6 
(4,232)
(3,166)

Net assets
  
317,740
264,280


Capital and reserves
  

Called up share capital 
 7 
100
100

Profit and loss account
  
317,640
264,180

  
317,740
264,280


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

Page 1

 
J P R MEDICAL LIMITED
REGISTERED NUMBER: 10833645
    
BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2023

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 28 March 2024.




Dr P P Gopinath
Director

The notes on pages 3 to 9 form part of these financial statements.

Page 2

 
J P R MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

1.


General information

J P R Medical Limited ("the Company") is a private company, limited by shares and is incorporated in England and Wales. The address of the registered office is Leytonstone House, 3 Hanbury Drive, Leytonstone, London, E11 1GA.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 3

 
J P R MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

2.Accounting policies (continued)

 
2.6

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.7

Exceptional items

Exceptional items are transactions that fall within the ordinary activities of the Company but are presented separately due to their size or incidence.

 
2.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following annual basis:

Office and computer equipment
-
20%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 4

 
J P R MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

2.Accounting policies (continued)

 
2.9

Debtors

Short-term debtors are measured at transaction price, less any impairment.

 
2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

 
2.11

Creditors

Short-term creditors are measured at the transaction price.

 
2.12

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.13

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Page 5

 
J P R MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

2.Accounting policies (continued)


2.13
Financial instruments (continued)

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

 
2.14

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 6

 
J P R MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

3.


Tangible fixed assets





Plant and machinery

£



Cost


At 1 July 2022
26,272


Additions
4,495



At 30 June 2023

30,767



Depreciation


At 1 July 2022
9,608


Charge for the year on owned assets
4,232



At 30 June 2023

13,840



Net book value



At 30 June 2023
16,927



At 30 June 2022
16,664


4.


Debtors

2023
2022
£
£


Other debtors
20,000
35,000

Accrued income
47,672
22,083

67,672
57,083


Page 7

 
J P R MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

5.


Creditors: Amounts falling due within one year

2023
2022
£
£

Trade creditors
3,000
-

Corporation tax
15,637
10,984

Other taxation and social security
1,572
1,029

Other creditors
6,087
6,702

Accruals
3,000
9,360

29,296
28,075



6.


Deferred taxation




2023


£






At beginning of year
3,166


Charged to profit or loss
1,066



At end of year
4,232

The provision for deferred taxation is made up as follows:

2023
2022
£
£


Accelerated capital allowances
4,232
3,166


7.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



50 (2022 - 50) Ordinary A shares of £1.00 each
50
50
50 (2022 - 50) Ordinary B shares of £1.00 each
50
50

100

100


Page 8

 
J P R MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

8.


Commitments under operating leases

At 30 June 2023 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2023
2022
£
£


Not later than 1 year
3,398
4,530

Later than 1 year and not later than 5 years
-
3,398

3,398
7,928


9.


Related party transactions

At the period end, the Company owed the directors £6,087 (2022 - £6,702).

 
Page 9